BTK and B-cell chronic lymphocytic leukemia: Alongside this, SINE compounds have also been shown to inhibit BCR signaling by downregulating the protein expression of BTK via enforced IκB nuclear retention in primary cells from patients with chronic lymphocytic leukemia (CLL) [16].